Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liver mitochondrial DNA damage and genetic variability of Cytochrome b – a key component of the respirasome – drive the severity of fatty liver disease
Carlos J. Pirola, Martín Garaycoechea, Diego Flichman, et al.
Journal of Internal Medicine (2020) Vol. 289, Iss. 1, pp. 84-96
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
Xiaohan Xu, Kyle L. Poulsen, Lijuan Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 207
Environmental Chemical Exposures and Mitochondrial Dysfunction: a Review of Recent Literature
Aalekhya Reddam, Sarah M. McLarnan, Allison Kupsco
Current Environmental Health Reports (2022) Vol. 9, Iss. 4, pp. 631-649
Open Access | Times Cited: 76
Pathophysiological mechanisms underlying MAFLD
Mohammad Shafi Kuchay, Narendra S. Choudhary, Sunil Kumar Mishra
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 6, pp. 1875-1887
Closed Access | Times Cited: 118
It Is High Time Physicians Thought of Natural Products for Alleviating NAFLD. Is There Sufficient Evidence to Use Them?
Giovanni Tarantino, Clara Balsano, Silvano Junior Santini, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13424-13424
Open Access | Times Cited: 83
Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease
Aigli‐Ioanna Legaki, Ioannis I. Moustakas, Michalina Sikorska, et al.
Current Obesity Reports (2022) Vol. 11, Iss. 3, pp. 126-143
Open Access | Times Cited: 57
Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
Eirini Martinou, Marinos Pericleous, Irena Stefanova, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 407-407
Open Access | Times Cited: 49
The Potential of the Mediterranean Diet to Improve Mitochondrial Function in Experimental Models of Obesity and Metabolic Syndrome
Mohamad Khalil, Harshitha Shanmugam, Hala Abdallah, et al.
Nutrients (2022) Vol. 14, Iss. 15, pp. 3112-3112
Open Access | Times Cited: 46
The Potential Role of Cellular Senescence in Non-Alcoholic Fatty Liver Disease
Cornelius Engelmann, Frank Tacke
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 652-652
Open Access | Times Cited: 40
Mitochondrial dysfunction: A promising therapeutic target for liver diseases
Ping Chen, Lichao Yao, Mengqin Yuan, et al.
Genes & Diseases (2023) Vol. 11, Iss. 3, pp. 101115-101115
Open Access | Times Cited: 34
Nutrients, Physical Activity, and Mitochondrial Dysfunction in the Setting of Metabolic Syndrome
Gabriela Lemos, Raquel Susana Torrinhas, Dan Linetzky Waitzberg
Nutrients (2023) Vol. 15, Iss. 5, pp. 1217-1217
Open Access | Times Cited: 26
Mitochondrial Dysfunction in Metabolic Dysfunction Fatty Liver Disease (MAFLD)
Ying Zhao, Yanni Zhou, Dan Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17514-17514
Open Access | Times Cited: 23
Gut microbial metabolites in MASLD: Implications of mitochondrial dysfunction in the pathogenesis and treatment
Ruhan Zhang, Zhaobo Yan, Huan Zhong, et al.
Hepatology Communications (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 17
Underlying Mechanisms behind the Brain–Gut–Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3694-3694
Open Access | Times Cited: 15
The Proteomics of MASLD Progression: Insights From Functional Analysis to Drive the Development of New Therapeutic Solutions
Carlos J. Pirola, Tomas Fernández Gianotti, Silvia Sookoian
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 1
Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology
Silvia Sookoian, Carlos J. Pirola
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 4, pp. 461-475
Open Access | Times Cited: 55
Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk
Siarhei A. Dabravolski, Evgeny E. Bezsonov, Mirza S. Baig, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4459-4459
Open Access | Times Cited: 40
Bridging lipid metabolism and mitochondrial genome maintenance
C W Boone, Samantha C. Lewis
Journal of Biological Chemistry (2024) Vol. 300, Iss. 8, pp. 107498-107498
Open Access | Times Cited: 6
Analysis of mitochondrial DNA cytochrome‐b (CYB) and ATPase‐6 gene mutations in COVID‐19 patients
Ebubekir Dirican, Şeyda Tuba Savrun, İsmail Erkan Aydın, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 3138-3146
Open Access | Times Cited: 20
Hypoxia-inducible factor-2α promotes fibrosis in non-alcoholic fatty liver disease by enhancing glutamine catabolism and inhibiting yes-associated protein phosphorylation in hepatic stellate cells
Ranran Yan, Hao Cai, Xiaofeng Zhou, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 4
Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response
Silvia Sookoian, Carlos J. Pirola
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S184-S195
Open Access | Times Cited: 19
Roads diverged in a wood: Proteins and RNAs encoded by cytochrome b (CYTB) gene in health and disease
Cijie Du, Baodan Chen, Yile Huang, et al.
Clinical and Translational Discovery (2025) Vol. 5, Iss. 1
Open Access
Unraveling Mechanisms of Genetic Risks in Metabolic Dysfunction–Associated Steatotic Liver Diseases: A Pathway to Precision Medicine
Xiang Zhang, Kyong‐Mi Chang, Jun Yu, et al.
Annual Review of Pathology Mechanisms of Disease (2025) Vol. 20, Iss. 1, pp. 375-403
Closed Access
Regular exercise alleviates metabolic dysfunction-associated steatohepatitis through rescuing mitochondrial oxidative stress and dysfunction in liver
Baoxuan Lin, Tong Wu, Mohammad Nasb, et al.
Free Radical Biology and Medicine (2025)
Closed Access
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes
Ming‐Ying Lu, Yu‐Ju Wei, Chih‐Wen Wang, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 10
Closed Access
Hormone correction of dysfunctional metabolic gene expression in stem cell-derived liver tissue
Alvile Kasarinaite, Maria Jiménez Ramos, Mariana Beltran-Sierra, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top